The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: -0.25 (-1.30%)
Spread: 2.00 (11.111%)
Open: 19.25
High: 19.25
Low: 19.00
Prev. Close: 19.25
BKY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Permitting Update

12 Jul 2021 13:45

RNS Number : 9596E
Berkeley Energia Limited
12 July 2021
 

BERKELEY ENERGIA LIMITED

 

NEWS RELEASE | 12 July 2021

 

Permitting Update

 

Berkeley Energia Limited ("Berkley" or the "Company") notes that the Board of the Nuclear Safety Council ("NSC") has issued an unfavourable report for the grant of the Authorisation for Construction for the uranium concentrate plant as a radioactive facility ("NSC II") following a board meeting held today. The Company has not received any official notification from the NSC however, it notes that the outcomes of the NSC board meeting have been published on their website.

 

The Company is extremely disappointed that the NSC has reached this decision and strongly refutes their assessment. As previously reported, all documentation submitted by the Company in relation to NCS II has been prepared following advice from independent, nationally and internationally recognised advisors and consultants who are experts in their field. Since the commencement of the process in 2016, the NSC has to date held six meetings with the Company and on seven occasions requested additional information in relation to NSC II; which the Company has promptly responded to with updated information. It is also important to note that, in the Company's view, a large part of the additional information requested by the NSC relates to the Authorisation for Operation for the uranium concentrate plant as a radioactive facility ("NSC III") which should only be dealt with following the award of NSC II. However, to ensure the process was conducted in a collaborative manner, the Company provided its responses to the NSC as requested.

 

It should also be noted that more than 120 previous permits and favourable reports have been granted by the relevant authorities at the local, regional, federal and European Union levels in relation to the Salamanca project, among which nine have been from the NSC. NSC II is the only pending approval required to commence full construction of the Salamanca mine.

 

The Company will strongly defend its position and will immediately consider the range of legal options available to it in relation to the adverse decision by the NSC.

 

The Company will continue to update the market on any material developments.

 

For further information please contact:

 

Robert Behets Francisco Bellón

Acting Managing Director Chief Operations Officer

+61 8 9322 6322 +34 91 555 1380

info@berkeleyenergia.com

 

This announcement as been authorised for release by Mr Robert Behets, Director.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFLFEEEFSELW
Date   Source Headline
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting
31st May 20237:00 amRNSExpiry of Unlisted Options
28th Apr 20237:00 amRNSQuarterly Report March 2023
3rd Apr 202312:12 pmRNSPermitting Update
14th Mar 20237:00 amRNSHalf-year Report
7th Feb 20234:40 pmRNSSecond Price Monitoring Extn
7th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20231:12 pmRNSPermitting Update
31st Jan 20237:00 amRNSQuarterly Report December 2022
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSExpiry of Unlisted Options
22nd Dec 20227:00 amRNSReport on Payments to Governments
1st Dec 20227:00 amRNSUnlisted Options
18th Nov 20227:00 amRNSNotification of Investment Dispute
15th Nov 20227:00 amRNSResult of AGM
9th Nov 20227:00 amRNSBerkeley establishes Spanish Advisory Committee
27th Oct 20227:00 amRNSQuarterly Report September 2022
20th Oct 20222:13 pmRNSPublication of a Prospectus
4th Oct 20227:00 amRNSNotice of AGM
23rd Sep 20224:35 pmRNSPrice Monitoring Extension
19th Sep 20227:45 amRNSDate of AGM
31st Aug 202210:00 amRNS2022 Annual Report
29th Jul 20227:00 amRNSQuarterly Report June 2022
5th Jul 20227:00 amRNSChange of Director’s Interest Notice
28th Jun 20227:00 amRNSStrengthening of Board with Spanish Based Director
29th Apr 20227:00 amRNSQuarterly Report March 2022
29th Apr 20227:00 amRNSQuarterly Report March 2022
5th Apr 20228:46 amRNSNotice of Initial Substantial Holder
5th Apr 20227:00 amRNSNotice of Initial Substantial Holder
1st Apr 20227:00 amRNSSettlement of OIA Claim
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.